Eiger Biopharms Company Profile
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
What is the competitive landscape for EIGER BIOPHARMS, and what generic alternatives to EIGER BIOPHARMS drugs are available?
EIGER BIOPHARMS has one approved drug.
There are two US patents protecting EIGER BIOPHARMS drugs.
There are nine patent family members on EIGER BIOPHARMS drugs in six countries.
Drugs and US Patents for Eiger Biopharms
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Eiger Biopharms | ZOKINVY | lonafarnib | CAPSULE;ORAL | 213969-002 | Nov 20, 2020 | RX | Yes | Yes | 7,838,531 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Eiger Biopharms | ZOKINVY | lonafarnib | CAPSULE;ORAL | 213969-001 | Nov 20, 2020 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Eiger Biopharms | ZOKINVY | lonafarnib | CAPSULE;ORAL | 213969-002 | Nov 20, 2020 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Eiger Biopharms | ZOKINVY | lonafarnib | CAPSULE;ORAL | 213969-001 | Nov 20, 2020 | RX | Yes | No | 7,838,531 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Eiger Biopharms Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Japan | 4436800 | ⤷ Try a Trial |
Canada | 2501464 | ⤷ Try a Trial |
Australia | 2003301446 | ⤷ Try a Trial |
European Patent Office | 1853265 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.